索引超出了数组界限。
1Black CJ, Ford AC. Global burden of irritable bowel syndrome:trends, predictions and risk factors[J]. Nat Rev Gastroenterol Hepatol, 2020, 17(8): 473-486.
2Huang KY, Wang FY, Lv M, et al. Irritable bowel syndrome:Epidemiology, overlap disorders, pathophysiology and treatment[J]. World J Gastroenterol, 2023, 29(26): 4120-4135.
3Rangan V, Ballou S, Shin A, et al. Use of treatments for irritable bowel syndrome and patient satisfaction based on the IBS in America survey[J]. Gastroenterology, 2020, 158(3): 786-788. e1.
4Oka P, Parr H, Barberio B, et al. Global prevalence of irritable bowel syndrome according to RomeⅢ or Ⅳ criteria: a systematic review and meta-analysis[J]. Lancet Gastroenterol Hepatol, 2020, 5(10):908-917.
5Arishi AM, Elmakki EE, HakamI OM, et al. Irritable bowel syndrome: prevalence and risk factors in Jazan Region, Saudi Arabia[J]. Cureus, 2021, 13(6): e15979.
6Grover M, Kolla BP, Pamarthy R, et al. Psychological, physical, and sleep comorbidities and functional impairment in irritable bowel syndrome: Results from a national survey of U.S. adults[J]. PLoS One, 2021, 16(1): e0245323.
7Margolis KG, Cryan JF, Mayer EA. The microbiota-gut-brain axis:from motility to mood[J]. Gastroenterology, 2021, 160(5): 1486-1501.
8 李思平, 刘丽平, 周荣. 急性心肌梗死后肠屏障功能障碍[J]. 国际心血管病杂志, 2023, 50(4): 201-204.
9Simon E, C?linoiu LF, Mitrea L, et al. Probiotics, prebiotics, and synbiotics: implications and beneficial effects against irritable bowel syndrome[J]. Nutrients, 2021, 13(6): 2112.
10 Yanai K, Ishibashi K, Morishita Y. MicroRNAs in irritable bowel syndrome: a systematic review[J]. Discov Med, 2022, 34(171): 7-18.
11 Thomas Dupont P, Izaguirre-Hernández IY, Remes-Troche JM. Contribution of microRNAs in the development of irritable bowel syndrome symptoms[J]. J Gastrointestin Liver Dis, 2023, 32(2): 230-240.
12 Yan W, Kan Z, Li Z, et al. Identification of potential microRNA-mRNA regulatory relationship pairs in irritable bowel syndrome with diarrhea[J]. Comb Chem High Throughput Screen, 2023, 26(8):1618-1628.
13 Yang W, Xu HW, Lu XR, et al. Overexpression of miR-122 impairs intestinal barrier function and aggravates acute pancreatitis by downregulating occludin expression[J]. Biochem Genet, 2022, 60(1):382-394.
14 Xing Y, Xue S, Wu J, et al. Serum exosomes derived from irritable bowel syndrome patient increase cell permeability via regulating miR-148b-5p/RGS2 signaling in human colonic epithelium cells[J]. Gastroenterol Res Pract, 2021, 2021: 6655900.
15 Fu X, Liu Y, Baranova A, et al. Deregulatory miRNA-BDNF network inferred from dynamic expression changes in schizophrenia[J]. Brain Sci, 2022, 12(2):167.
16 Wang P, Chen FX, Du C, et al. Increased production of BDNF in colonic epithelial cells induced by fecal supernatants from diarrheic IBS patients[J]. Sci Rep, 2015, 5: 10121.
17 Konturek TJ, Martinez C, Niesler B, et al. The role of brain-derived neurotrophic factor in irritable bowel syndrome[J]. Front Psychiatry, 2021, 11: 531385.
18 Zhang Y, Qin G, Liu DR, et al. Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome[J]. World J Gastroenterol, 2019, 25(2): 269-281.
19 Colucci-D'Amato L, Speranza L, Volpicelli F. Neurotrophic factor BDNF, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer[J]. Int J Mol Sci, 2020, 21(20): 7777.
20 Fu Y, Lin YM, Winston JH, et al. Role of brain-derived neurotrophic factor in the pathogenesis of distention-associated abdominal pain in bowel obstruction[J]. Neurogastroenterol Motil, 2018, 30(10):e13373.
21 Singh A, Singh J, Rattan S. Evidence for the presence and release of BDNF in the neuronal and non-neuronal structures of the internal anal sphincter[J]. Neurogastroenterol Motil, 2022, 34(4): e14099.
22 Pan XQ, Malykhina AP. Estrous cycle dependent fluctuations of regulatory neuropeptides in the lower urinary tract of female rats upon colon-bladder cross-sensitization[J]. PLoS One, 2014, 9(5):e94872.
23 Zhao Y, Jiang HL, Shi Y, et al. Electroacupuncture alleviates visceral hypersensitivity in IBS-D rats by inhibiting EGCs activity through regulating BDNF/TrkB signaling pathway[J]. Evid Based Complement Alternat Med, 2022, 2022: 2497430.
24 L M, Mitra P, Goyal T, et al. Association of blood lead levels with neurobehavior and BDNF expression in school going children[J]. J Trace Elem Med Biol, 2021, 66: 126749.
25 Lin YM, Fu Y, Radhakrishnan R, et al. Stretch-induced BDNF in colon smooth muscle plays a critical role in obstruction associated visceral hypersensitivity by altering Kv function in primary sensory neurons[J]. Gastroenterology, 2017, 152 (Suppl 1): S203-S204.
26 Prochnik A, Burgue?o AL, Rubinstein MR, et al. Sexual dimorphism modulates metabolic and cognitive alterations under HFD nutrition and chronic stress exposure in mice. Correlation between spatial memory impairment and BDNF mRNA expression in hippocampus and spleen[J]. Neurochem Int, 2022, 160: 105416.
27 Fukumoto M, Takeuchi T, Koubayashi E, et al. Induction of brain-derived neurotrophic factor in enteric glial cells stimulated by interleukin-1β via a c-Jun N-terminal kinase pathway[J]. J Clin Biochem Nutr, 2020, 66(2): 103-109.
28 Short AK, Bui V, ZbukviC IC, et al. Sex-dependent effects of chronic exercise on cognitive flexibility but not hippocampal Bdnf in aging mice[J]. Neuronal Signal, 2022, 6(1): NS20210053.
29 Bukalo O, Lee PR, Fields RD. BDNF mRNA abundance regulated by antidromic action potentials and AP-LTD in hippocampus[J]. Neurosci Lett, 2016, 635: 97-102.
30 Han L, Zhao L, Zhou Y, et al. Altered metabolome and microbiome features provide clues in understanding irritable bowel syndrome and depression comorbidity[J]. ISME J, 2022, 16(4): 983-996.
31 Guo Q, Lin H, Chen P, et al. Dynamic changes of intestinal flora in patients with irritable bowel syndrome combined with anxiety and depression after oral administration of enterobacteria capsules[J]. Bioengineered, 2021, 12(2): 11885-11897.
32 Simpson CA, Mu A, Haslam N, et al. Feeling down? A systematic review of the gut microbiota in anxiety/depression and irritable bowel syndrome[J]. J Affect Disord, 2020, 266: 429-446.
33 Eijsbouts C, Zheng T, Kennedy NA, et al. Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders[J]. Nat Genet, 2021, 53(11): 1543-1552.
34 Sochal M, Ditmer M, Binienda A, et al. Relation between selected sleep parameters, depression, anti-tumor necrosis factor therapy, and the brain-derived neurotrophic factor pathway in inflammatory bowel disease[J]. Metabolites, 2023, 13(3): 450.
35 Aldhshan MS, MizunO TM. Effect of environmental enrichment on aggression and the expression of brain-derived neurotrophic factor transcript variants in group-housed male mice[J]. Behav Brain Res, 2022, 433: 113986.
36 Cattaneo A, Bocchio-Chiavetto L, Zanardini R, et al. Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment[J]. Int J Neuropsychopharmacol, 2010, 13(1): 103-108.
37 Lee BH, Kim YK. BDNF mRNA expression of peripheral blood mononuclear cells was decreased in depressive patients who had or had not recently attempted suicide[J]. J Affect Disord, 2010, 125(1-3): 369-373.